Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Renal Insufficiency × melflufen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 5 Renal Insufficiency 1

Interventions

Dexamethasone 2 Azacitidine 2 sacubitril and valsartan sodium hydrate drug combination 1 regorafenib 1 pevonedistat 1 melflufen 1 glucarpidase 1 gamma-Glutamyl Hydrolase 1 copanlisib 1 carfilzomib 1 Thalidomide 1 Methotrexate 1 Leucovorin 1 L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1 Cyclophosphamide 1 Bortezomib 1 Bendamustine Hydrochloride 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03639610 2023-03-10

BRIDGE

Oncopeptides AB

Phase 2 Terminated

35 enrolled 33 charts

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡